169 related articles for article (PubMed ID: 3076782)
1. Blood rheology changes during bezafibrate treatment.
Caimi G; Francavilla G; Romano A; Catania A; Santonocito G; Sarno A
Br J Clin Pract; 1988 Nov; 42(11):456-8. PubMed ID: 3076782
[TBL] [Abstract][Full Text] [Related]
2. Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients.
Niort G; Bulgarelli A; Cassader M; Pagano G
Atherosclerosis; 1988 Jun; 71(2-3):113-9. PubMed ID: 3401284
[TBL] [Abstract][Full Text] [Related]
3. Using serial haemorheological parameters to assess clinical status in sickle cell anaemia patients in vaso-occlussive crisis.
Awodu OA; Famodu AA; Ajayi OI; Enosolease ME; Olufemi OY; Olayemi E
Clin Hemorheol Microcirc; 2009; 41(2):143-8. PubMed ID: 19252237
[TBL] [Abstract][Full Text] [Related]
4. [Effects of bezafibrate in the diet of hypertensive patients with dyslipidemia and hyperfibrinogenemia].
Vázquez-Chávez C; Salinas-Orozco S; Gómez-Díaz RA; Rosso-Juárez MM; Moreno-Vázquez K; Nissen-Torres T; Argüero-Sánchez R
Rev Invest Clin; 1998; 50(6):491-6. PubMed ID: 10070221
[TBL] [Abstract][Full Text] [Related]
5. [Hemorrheologic disorders in obese patients. Study of the viscosity of the blood, erythrocytes, plasma, fibrinogen and the erythrocyte filtration index].
Craveri A; Tornaghi G; Paganardi L; Ranieri R; Leonardi G; Di Bella M
Minerva Med; 1987 Jul; 78(13):899-906. PubMed ID: 3601135
[TBL] [Abstract][Full Text] [Related]
6. [Effect of balneotherapeutic measures on blood rheologic parameters in patients with atherosclerosis].
Winkler R; Klieber M
Wien Klin Wochenschr; 1986 Aug; 98(15):490-5. PubMed ID: 3765637
[TBL] [Abstract][Full Text] [Related]
7. [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
Ciuffetti G; Mercuri M; Lombardini R; Palazzetti D; Rizzo MT; Parnetti L
Minerva Med; 1989 Nov; 80(11):1237-40. PubMed ID: 2689916
[TBL] [Abstract][Full Text] [Related]
8. [Increase in erythrocyte and plasma viscosity in patients with atherosclerotic vasculopathy of different sites].
Craveri A; Tornaghi G; Paganardi L; Di Bella M; Gallo E; Stanzani M
Minerva Med; 1987 Jun; 78(12):815-22. PubMed ID: 3601129
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel: hemorheological effects in subjects with subclinical atherosclerosis.
Ciuffetti G; Lombardini R; Pirro M; Lupattelli G; Mannarino E
Clin Hemorheol Microcirc; 2001; 25(1):31-9. PubMed ID: 11790868
[TBL] [Abstract][Full Text] [Related]
10. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
[TBL] [Abstract][Full Text] [Related]
11. [Hemorrheology and quality of life in fibrinogen- and lipid-lowering therapy].
Walzl M; Lechner H; Walzl B; Kleinert G; Schied G; Freidl W; Bertha G
Schweiz Med Wochenschr; 1993 Oct; 123(40):1875-82. PubMed ID: 8211041
[TBL] [Abstract][Full Text] [Related]
12. [Effect of molsidomine on rheological parameters and the incidence of cardiovascular events].
Wöhrle J; Nusser T; Hoffmeister A; Kestler HA; Grebe OC; Höher M; Hombach V; Koenig W; Kochs M
Dtsch Med Wochenschr; 2003 Jun; 128(24):1333-7. PubMed ID: 12802741
[TBL] [Abstract][Full Text] [Related]
13. Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Treatment.
Cortellaro M; Cofrancesco E; Boschetti C; Cortellaro F; Mancini M; Mariani M; Paoletti R
Thromb Haemost; 2000 Apr; 83(4):549-53. PubMed ID: 10780315
[TBL] [Abstract][Full Text] [Related]
14. Correlation between hemorheologic parameters and carotid atherosclerosis in stroke.
Mercuri M; Orecchini G; Susta A; Tazza D; Ciuffetti G
Angiology; 1989 Apr; 40(4 Pt 1):283-6. PubMed ID: 2650579
[TBL] [Abstract][Full Text] [Related]
15. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F
Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
[TBL] [Abstract][Full Text] [Related]
16. The hemorheological effects of raloxifene in postmenopausal women with osteoporosis. Results of a 3-year placebo-controlled clinical trial.
Shand B; Gilchrist N; Blackwell T; March R
Clin Hemorheol Microcirc; 2002; 26(4):249-55. PubMed ID: 12122230
[TBL] [Abstract][Full Text] [Related]
17. [Association between fibrinogen and blood sedimentation rate in combined extracorporal and fibrinogen reducing drug therapy].
Walzl M; Walzl B; Schied G; Lechner H
Wien Klin Wochenschr; 1993; 105(14):404-7. PubMed ID: 8367976
[TBL] [Abstract][Full Text] [Related]
18. [Hemorheologic changes in chronic polyarthritis].
Schöps P; Seichert N; Thies W; Erdl R; Schattenkirchner M; Ernst E
Z Rheumatol; 1988; 47(1):52-7. PubMed ID: 2453101
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline attenuates the increase in whole blood viscosity after transfusion.
Bacher A; Eggensperger E; Koppensteiner R; Mayer N; Klimscha W
Acta Anaesthesiol Scand; 2005 Jan; 49(1):41-6. PubMed ID: 15675980
[TBL] [Abstract][Full Text] [Related]
20. No change of whole blood of plasma viscosity in cardiac patients after subcutaneous calcium heparin.
Girolami A; Patrassi G; Bova G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(3):391-9. PubMed ID: 80367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
